Susquehanna Fundamental Investments LLC Invests $1.23 Million in Balchem Co. (NASDAQ:BCPC)

Susquehanna Fundamental Investments LLC acquired a new position in Balchem Co. (NASDAQ:BCPC - Free Report) in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor acquired 7,517 shares of the basic materials company's stock, valued at approximately $1,225,000.

Several other institutional investors have also recently modified their holdings of the company. Covestor Ltd boosted its position in Balchem by 93.8% during the fourth quarter. Covestor Ltd now owns 157 shares of the basic materials company's stock valued at $26,000 after buying an additional 76 shares during the period. Westside Investment Management Inc. purchased a new stake in Balchem during the 3rd quarter valued at about $27,000. R Squared Ltd bought a new position in Balchem during the 4th quarter worth approximately $29,000. Federated Hermes Inc. purchased a new position in Balchem in the 4th quarter worth approximately $33,000. Finally, Wilmington Savings Fund Society FSB bought a new stake in Balchem in the third quarter valued at approximately $35,000. 87.91% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently issued reports on BCPC. Sidoti raised shares of Balchem to a "hold" rating in a research note on Tuesday, February 25th. StockNews.com lowered shares of Balchem from a "buy" rating to a "hold" rating in a report on Tuesday, February 25th. Finally, HC Wainwright set a $180.00 price objective on shares of Balchem and gave the company a "buy" rating in a research note on Monday, April 28th.

Balchem Trading Down 0.4 %

Shares of Balchem stock traded down $0.66 during midday trading on Wednesday, reaching $163.03. 10,022 shares of the company's stock traded hands, compared to its average volume of 133,993. The company has a market cap of $5.32 billion, a PE ratio of 5.74, a price-to-earnings-growth ratio of 4.41 and a beta of 0.93. The stock has a 50 day moving average of $162.92 and a 200-day moving average of $166.54. Balchem Co. has a 12 month low of $145.70 and a 12 month high of $186.03. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.16 and a current ratio of 1.99.

Balchem (NASDAQ:BCPC - Get Free Report) last posted its earnings results on Thursday, April 24th. The basic materials company reported $1.22 EPS for the quarter, missing the consensus estimate of $1.25 by ($0.03). Balchem had a return on equity of 11.37% and a net margin of 13.47%. The company had revenue of $250.52 million during the quarter, compared to analysts' expectations of $245.70 million. During the same period in the prior year, the business posted $1.03 earnings per share. The company's revenue for the quarter was up 4.5% on a year-over-year basis. As a group, equities analysts expect that Balchem Co. will post 4.64 EPS for the current fiscal year.

Balchem Profile

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.